Octapharma

Part of a vital chain

Read Our Annual Report 2025

News & stories

Check out our latest stories

FDA Approves New 2-Gram Presentation of Fibryga®, Enhancing Convenience and Precision in Treating Acquired Fibrinogen Deficiency

Innovation and science

How Big Data is changing the game at Octapharma

Be a hero time and time again

From survivor to advocate

Patient engagement

Octapharma takes an active role in our community

We sponsor and support organizations worldwide.

Learn how we engage with patients

Our products

Products

Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.